Common Stock, Shares, Outstanding of Ernexa Therapeutics Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Ernexa Therapeutics Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Ernexa Therapeutics Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 7,854,000, a 129% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Ernexa Therapeutics Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 7,854,000 +4,428,000 +129% 31 Dec 2025 10-K 13 Mar 2026 2025 FY
Q3 2025 7,849,000 +2,438,000 +45% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 7,483,000 +2,072,000 +38% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 52,250,000 +46,840,000 +866% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 3,426,000 -1,984,000 -37% 31 Dec 2024 10-K 13 Mar 2026 2025 FY
Q3 2024 5,411,000 +1,000 +0.02% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 5,411,000 +1,000 +0.02% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 5,410,000 +283,000 +5.5% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 5,410,000 +283,000 +5.5% 31 Dec 2023 10-K 12 Mar 2025 2024 FY
Q3 2023 5,410,000 +2,468,000 +84% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 5,410,000 -52,059,000 -91% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 5,127,000 -52,325,000 -91% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 5,127,000 +2,526,000 +97% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 2,942,000 -49,101,818 -94% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 57,469,000 +12,761,618 +29% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 57,452,000 +15,946,002 +38% 31 Mar 2022 10-Q 01 Jul 2022 2022 Q1
Q4 2021 2,601,000 +2,601,000 31 Dec 2021 10-K 20 Mar 2023 2022 FY
Q3 2021 52,043,818 +49,091,818 +1663% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 44,707,382 +41,769,382 +1422% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 41,505,998 +38,579,998 +1319% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 0 -2,901,000 -100% 31 Dec 2020 10-K/A 01 Jul 2022 2021 FY
Q3 2020 2,952,000 +57,000 +2% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 2,938,000 +56,000 +1.9% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 2,926,000 +48,000 +1.7% 31 Mar 2020 10-Q 20 May 2020 2020 Q1
Q4 2019 2,901,000 +26,000 +0.9% 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 2,895,000 +23,000 +0.8% 30 Sep 2019 10-Q 01 Nov 2019 2019 Q3
Q2 2019 2,882,000 +16,000 +0.56% 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 2,878,000 +357,000 +14% 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 2,875,000 +354,000 +14% 31 Dec 2018 10-K 19 Mar 2020 2019 FY
Q3 2018 2,872,000 +356,000 +14% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 2,866,000 +353,000 +14% 30 Jun 2018 10-Q 06 Aug 2018 2018 Q2
Q1 2018 2,521,000 +37,000 +1.5% 31 Mar 2018 10-Q 11 May 2018 2018 Q1
Q4 2017 2,521,000 +260,000 +11% 31 Dec 2017 10-K 22 Mar 2019 2018 FY
Q3 2017 2,516,000 +667,000 +36% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 2,513,000 +664,000 +36% 30 Jun 2017 10-Q 04 Aug 2017 2017 Q2
Q1 2017 2,484,000 -89,955,000 -97% 31 Mar 2017 10-Q 04 May 2017 2017 Q1
Q4 2016 2,261,000 +412,000 +22% 31 Dec 2016 10-K 09 Mar 2018 2017 FY
Q3 2016 1,849,000 -90,563,000 -98% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 1,849,000 -90,563,000 -98% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 92,439,000 +58,000 +0.06% 31 Mar 2016 10-Q 09 May 2016 2016 Q1
Q4 2015 1,849,000 -90,521,000 -98% 31 Dec 2015 10-K 09 Mar 2017 2016 FY
Q3 2015 92,412,000 +118,000 +0.13% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 92,412,000 +749,000 +0.82% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 92,381,000 +13,658,000 +17% 31 Mar 2015 10-Q 08 May 2015 2015 Q1
Q4 2014 92,370,000 +13,721,000 +17% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q3 2014 92,294,000 +92,222,227 +128492% 30 Sep 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 91,663,000 +91,591,396 +127914% 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 78,723,000 +78,651,484 +109977% 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 78,649,000 +7,526,000 +11% 31 Dec 2013 10-K 27 Mar 2015 2014 FY
Q3 2013 71,773 +728 +1% 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 71,604 +559 +0.79% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 71,516 +518 +0.73% 31 Mar 2013 10-Q 13 May 2013 2013 Q1
Q4 2012 71,123,000 +71,062,073 +116635% 31 Dec 2012 10-K 31 Mar 2014 2013 FY
Q3 2012 71,045 +10,138 +17% 30 Sep 2012 10-Q 09 Nov 2012 2012 Q3
Q2 2012 71,045 +10,153 +17% 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 70,998 31 Mar 2012 10-Q 11 May 2012 2012 Q1
Q4 2011 60,927 +176 +0.29% 31 Dec 2011 10-K 29 Mar 2013 2012 FY
Q3 2011 60,907 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 60,892 30 Jun 2011 10-Q 12 Aug 2011 2011 Q2
Q4 2010 60,751 31 Dec 2010 10-K 30 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.